Skip to content

A Study to Check the Safety and Effectiveness of a Skincare Product for Reducing Tanning and Improving Skin Brightness

To evaluate the in vivo safety and efficacy of a skin care formulation in terms of its efficacy to reduce tanning and to improve the skin brightness on healthy female subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101062
Enrollment
33
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Skin Brightening Soap: The product is applied on the whole face and both arms once a day for a period of 3 days Control Intervention1: Nil: NA

Sponsors

Idam Natural Welness pvt. ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian Female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having dull skin

Exclusion criteria

Exclusion criteria: 1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2)Having refused to give his/her assent by not signing the consent form. 3)Taking part in another study liable to interfere with this study. 4) Being diabetic. 5) Being asthmatic. 6) Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 7)Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin). 8) Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 9) Having undergone a surgery requiring a general anesthesia of more than one hour in the past 6 months. 10) Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.

Design outcomes

Primary

MeasureTime frame
safety, Tan reduction and to improve the skin brightnessTimepoint: Baseline, 15 min, 1 day and 3 days after product application

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026